We are at a watershed brought on by the recent introduction of highly effective obesity medications. As the development of these medications continues to evolve, obesity research will hold a prominent position over the next several decades. These new pharmacotherapeutics can potentially help transform the lives and health of people with obesity, and hold promise for the health of our nation and world.
Yale Obesity Research Center (Y-Weight)
The United States is at the forefront of the global obesity epidemic with estimates indicating that half of Americans will have obesity by 2030 (body mass index =30kg/m2). Obesity is a complex, chronic disease in and of itself and, additionally, it has driven substantial increases in obesity-related conditions, such as Type 2 diabetes, cardiovascular disease, and even some types of cancer.
How to Help
Y-Weight Research
The focus of Y-Weight (the Yale Obesity Research Center) is to investigate novel obesity medications and to use these medications to help us better understand the biology of obesity. The three areas of clinical research at Y-Weight include: 1) human physiology studies (to better understand the biology of obesity), 2) clinical trials (to assess the efficacy and safety of novel obesity medications), and 3) outcomes research (to investigate how these medications are used work in the real-world and impact population health).
- May 25, 2026
Back to School: What Mitochondria Really Do
- May 22, 2026Source: The New York Times
Experimental Drug Yields Dramatic Weight Loss
- May 21, 2026Source: PEOPLE (with Ania Jastreboff, MD)
Eli Lilly's Powerful New Weight-Loss Drug Shows Dramatic Results
- May 21, 2026Source: Daily Mail Online (with Ania Jastreboff, MD)
New drug that curbs appetite and burns calories is most powerful weight-loss treatment ever and like 'exercise in a jab'